Busey Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $24.8M | Sell |
36,740
-670
| -2% | -$398K | 0.59% | 42 |
|
|
2026
Q2 | $18.8M | Buy |
37,410
+415
| +1% | +$199K | 0.45% | 54 |
|
|
2026
Q1 | $18.2M | Buy |
36,995
+1,341
| +4% | +$728K | 0.49% | 50 |
|
|
2025
Q4 | $20.7M | Buy |
35,654
+112
| +0.3% | +$63.3K | 0.54% | 47 |
|
|
2025
Q3 | $17.2M | Buy |
35,542
+5,007
| +16% | +$2.33M | 0.48% | 55 |
|
|
2025
Q2 | $12.4M | Sell |
30,535
-180
| -0.6% | -$75.3K | 0.38% | 67 |
|
|
2025
Q1 | $15.3M | Buy |
30,715
+484
| +2% | +$262K | 0.52% | 54 |
|
|
2024
Q4 | $15.7M | Buy |
30,231
+1,044
| +4% | +$574K | 0.52% | 49 |
|
|
2024
Q3 | $18.1M | Buy |
29,187
+300
| +1% | +$178K | 0.59% | 47 |
|
|
2024
Q2 | $16M | Buy |
28,887
+873
| +3% | +$500K | 0.55% | 51 |
|
|
2024
Q1 | $16.3M | Sell |
28,014
-337
| -1% | -$189K | 0.58% | 50 |
|
|
2023
Q4 | $15M | Sell |
28,351
-2,817
| -9% | -$1.36M | 0.58% | 48 |
|
|
2023
Q3 | $15.8M | Buy |
31,168
+612
| +2% | +$326K | 0.67% | 43 |
|
|
2023
Q2 | $15.9M | Buy |
30,556
+16
| +0.1% | +$8.63K | 0.65% | 45 |
|
|
2023
Q1 | $17.6M | Buy |
30,540
+988
| +3% | +$557K | 0.74% | 38 |
|
|
2022
Q4 | $16.3M | Buy |
29,552
+1,969
| +7% | +$1.04M | 0.73% | 40 |
|
|
2022
Q3 | $14M | Buy |
27,583
+1,914
| +7% | +$1.07M | 0.69% | 42 |
|
|
2022
Q2 | $13.9M | Buy |
25,669
+469
| +2% | +$258K | 0.65% | 44 |
|
|
2022
Q1 | $14.9M | Buy |
25,200
+952
| +4% | +$547K | 0.59% | 45 |
|
|
2021
Q4 | $16.2M | Buy |
24,248
+119
| +0.5% | +$74.3K | 0.61% | 39 |
|
|
2021
Q3 | $13.8M | Buy |
24,129
+2,722
| +13% | +$1.49M | 0.56% | 51 |
|
|
2021
Q2 | $10.8M | Buy |
21,407
+831
| +4% | +$392K | 0.5% | 62 |
|
|
2021
Q1 | $9.39M | Buy |
20,576
+680
| +3% | +$325K | 0.47% | 63 |
|
|
2020
Q4 | $9.27M | Buy |
19,896
+278
| +1% | +$130K | 0.53% | 50 |
|
|
2020
Q3 | $8.66M | Buy |
19,618
+144
| +0.7% | +$59.5K | 0.55% | 49 |
|
|
2020
Q2 | $7.06M | Buy |
19,474
+432
| +2% | +$145K | 0.49% | 55 |
|
|
2020
Q1 | $5.4M | Buy |
19,042
+943
| +5% | +$297K | 0.44% | 62 |
|
|
2019
Q4 | $5.88M | Buy |
18,099
+6,377
| +54% | +$1.93M | 0.39% | 66 |
|
|
2019
Q3 | $3.42M | Buy |
11,722
+2,349
| +25% | +$673K | 0.25% | 97 |
|
|
2019
Q2 | $2.75M | Buy |
9,373
+671
| +8% | +$185K | 0.26% | 83 |
|
|
2019
Q1 | $2.38M | Buy |
+8,702
| New | +$2.17M | 0.22% | 90 |
|
Other funds holding TMO
Busey Bank's TMO Position: Q3 2026 in Review
Busey Bank reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q3 2026, selling an estimated $398K and leaving 36,740 shares worth $24.8M. The position accounts for 0.59% of the portfolio, ranked #42.
Busey Bank first reported a position in TMO in Q1 2019 and has held it in 31 quarters since. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Busey Bank held 36,740 shares of Thermo Fisher Scientific worth $24.8M as of Q3 2026.
- Busey Bank sold 670 Thermo Fisher Scientific shares in Q3 2026, an estimated $398K.
- Thermo Fisher Scientific made up 0.59% of Busey Bank's portfolio in Q3 2026, its #42 holding.
- Busey Bank first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 31 quarters since.
- 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Busey Bank's 13F filing for Q3 2026, filed 26 Oct 2026.